Structural characterization of Giardia duodenalis thioredoxin reductase (gTrxR) and computational analysis of its interaction with NBDHEX.

Giardia duodenalis is a microaerophilic parasite that colonizes the upper portions of the small intestine of humans. Giardia infection is a major contributor to diarrheal disease worldwide. Nitroheterocycles (e.g. metronidazole) or benzimidazoles (e.g. albendazole) are the most commonly used therapeutic agents. Unfortunately, their efficacy is reduced by low compliance or resistance phenomena. We recently discovered that the antitumoral drug 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) is active against G. duodenalis trophozoites and its mode of action is linked to inhibition of thioredoxin reductase (gTrxR), a key component of Giardia redox system: gTrxR provides efficient defenses against reactive oxygen species (ROS), it is a target of 5-nitroimidazoles antiparasitic drugs and also contributes to their metabolism. However, the exact mechanism responsible for the gTrxR inhibition mediated by this chemical class of antigiardial compounds is yet to be defined. The definition of the structural determinants of activity against gTrxR could be important for the identification of novel drugs endowed with an innovative mode of action. With this aim, we solved the crystal structure of gTrxR and we analyzed in silico the binding mode of NBDHEX. The data presented herein could guide the development of NBDHEX derivatives tailored for selective inhibition of gTrxR as antigiardial agents.

[1]  B. Svensson,et al.  Biological Crystallography Structure of Hordeum Vulgare Nadph-dependent Thioredoxin Reductase 2. Unwinding the Reaction Mechanism , 2022 .

[2]  G. Schneider,et al.  High-resolution structures of oxidized and reduced thioredoxin reductase from Helicobacter pylori. , 2007, Acta crystallographica. Section D, Biological crystallography.

[3]  L. Eckmann,et al.  Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia. , 2011, The Journal of antimicrobial chemotherapy.

[4]  Ian W. Davis,et al.  Structure validation by Cα geometry: ϕ,ψ and Cβ deviation , 2003, Proteins.

[5]  Simone Brogi,et al.  Discovery and Cardioprotective Effects of the First Non-Peptide Agonists of the G Protein-Coupled Prokineticin Receptor-1 , 2015, PloS one.

[6]  E. Novellino,et al.  From (+)-epigallocatechin gallate to a simplified synthetic analogue as a cytoadherence inhibitor for P. falciparum , 2014 .

[7]  Simone Brogi,et al.  Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds. , 2013, European journal of medicinal chemistry.

[8]  Feng Chen,et al.  Genomic Minimalism in the Early Diverging Intestinal Parasite Giardia lamblia , 2007, Science.

[9]  S. Müller,et al.  The diversity and evolution of thioredoxin reductase: new perspectives. , 2002, Trends in parasitology.

[10]  M. Müller,et al.  Reductive activation of nitroimidazoles in anaerobic microorganisms. , 1986, Biochemical pharmacology.

[11]  M. Lalle.  Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives. , 2010, Infectious disorders drug targets.

[12]  W. L. Jorgensen,et al.  Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .

[13]  M. Ludwig,et al.  Twists in catalysis: alternating conformations of Escherichia coli thioredoxin reductase. , 2000, Science.

[14]  J Kuriyan,et al.  Crystal Structure of Escherichia coli Thioredoxin Reductase Refined at 2 Å Resolution , 1994 .

[15]  M. R. Crampton,et al.  Kinetic and equilibrium studies of the reactions of 4-nitrobenzofurazan and some derivatives with sulfite ions in water. Evidence for the Boulton–Katritzky rearrangement in a σ-adduct , 2002 .

[16]  J. Gut,et al.  A Reprofiled Drug, Auranofin, Is Effective against Metronidazole-Resistant Giardia lamblia , 2013, Antimicrobial Agents and Chemotherapy.

[17]  P. Upcroft,et al.  Free radical detoxification in Giardia duodenalis. , 1995, Molecular and biochemical parasitology.

[18]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[19]  A. Bocedi,et al.  Proteomic and functional analyses reveal pleiotropic action of the anti-tumoral compound NBDHEX in Giardia duodenalis , 2017, International journal for parasitology. Drugs and drug resistance.

[20]  I. Wilson,et al.  Nitroimidazole Action in Entamoeba histolytica: A Central Role for Thioredoxin Reductase , 2007, PLoS biology.

[21]  Giovanni Antonini,et al.  7-Nitro-2,1,3-benzoxadiazole Derivatives, a New Class of Suicide Inhibitors for Glutathione S-Transferases , 2005, Journal of Biological Chemistry.

[22]  Simone Brogi,et al.  Rational design of the first difluorostatone-based PfSUB1 inhibitors. , 2014, Bioorganic & medicinal chemistry letters.

[23]  Simone Brogi,et al.  Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation. , 2016, European journal of medicinal chemistry.

[24]  E. Novellino,et al.  Synthetic spirocyclic endoperoxides: new antimalarial scaffolds , 2015 .

[25]  G. Widmer,et al.  A comparison of the Giardia lamblia trophozoite and cyst transcriptome using microarrays , 2011, BMC Microbiology.

[26]  P. Upcroft,et al.  Characterisation and purification of pyruvate:ferredoxin oxidoreductase from Giardia duodenalis. , 1996, Molecular and biochemical parasitology.

[27]  E. Novellino,et al.  Targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors for developing effective antipsychotics: synthesis, biological characterization, and behavioral studies. , 2014, Journal of medicinal chemistry.

[28]  M. Müller.  Mode of action of metronidazole on anaerobic bacteria and protozoa. , 1983, Surgery.

[29]  D. Sanders,et al.  Thioredoxin System from Deinococcus radiodurans , 2009, Journal of bacteriology.

[30]  M. Ludwig,et al.  Crystal structure of reduced thioredoxin reductase from Escherichia coli: Structural flexibility in the isoalloxazine ring of the flavin adenine dinucleotide cofactor , 1999, Protein science : a publication of the Protein Society.

[31]  E. Novellino,et al.  Plasmodium falciparum subtilisin-like protease 1: discovery of potent difluorostatone-based inhibitors , 2015 .

[32]  Kai Zhu,et al.  Docking Covalent Inhibitors: A Parameter Free Approach To Pose Prediction and Scoring , 2014, J. Chem. Inf. Model..

[33]  R. Cammack,et al.  The generation of metronidazole radicals in hydrogenosomes isolated from Trichomonas vaginalis. , 1985, Journal of general microbiology.

[34]  Michael J. Dagley,et al.  Drug resistance in Giardia duodenalis. , 2015, Biotechnology advances.

[35]  J. Stadlmann,et al.  Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance , 2009, Molecular microbiology.

[36]  E. Novellino,et al.  Multifunctional cholinesterase and amyloid Beta fibrillization modulators. Synthesis and biological investigation. , 2013, ACS medicinal chemistry letters.

[37]  S. Camerini,et al.  The FAD-dependent glycerol-3-phosphate dehydrogenase of Giardia duodenalis: an unconventional enzyme that interacts with the g14-3-3 and it is a target of the antitumoral compound NBDHEX , 2015, Front. Microbiol..

[38]  M. Arkin,et al.  A high throughput drug screen for Entamoeba histolytica identifies a new lead and target , 2012, Nature Medicine.

[39]  J. Borrell,et al.  Development of HuperTacrines as non-toxic, cholinesterase inhibitors for the potential treatment of Alzheimer's disease. , 2015, Mini reviews in medicinal chemistry.

[40]  S. Cacciò,et al.  Zoonotic potential of Giardia. , 2013, International journal for parasitology.

[41]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[42]  Simone Brogi,et al.  Disease‐Modifying Anti‐Alzheimer's Drugs: Inhibitors of Human Cholinesterases Interfering with β‐Amyloid Aggregation , 2014, CNS neuroscience & therapeutics.

[43]  D I Edwards,et al.  Nitroimidazole drugs--action and resistance mechanisms. I. Mechanisms of action. , 1993, The Journal of antimicrobial chemotherapy.

[44]  Simone Brogi,et al.  Structure-based discovery of the first non-covalent inhibitors of Leishmania major tryparedoxin peroxidase by high throughput docking , 2015, Scientific Reports.

[45]  Alejandro E Leroux,et al.  Low-molecular-mass antioxidants in parasites. , 2012, Antioxidants & redox signaling.

[46]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[47]  R. Schirmer,et al.  Thioredoxin reductase two modes of catalysis have evolved. , 2000, European journal of biochemistry.

[48]  Simone Brogi,et al.  In silico study of subtilisin-like protease 1 (SUB1) from different Plasmodium species in complex with peptidyl-difluorostatones and characterization of potent pan-SUB1 inhibitors , 2016, Journal of molecular graphics & modelling.

[49]  P. Upcroft,et al.  Anaerobic bacterial metabolism in the ancient eukaryote Giardia duodenalis. , 1998, International journal for parasitology.

[50]  R. Abagyan,et al.  X-ray structures of thioredoxin and thioredoxin reductase from Entamoeba histolytica and prevailing hypothesis of the mechanism of Auranofin action. , 2016, Journal of structural biology.

[51]  A. Thompson,et al.  Giardia and Cryptosporidium join the 'Neglected Diseases Initiative'. , 2006, Trends in parasitology.

[52]  A. Vagin,et al.  MOLREP: an Automated Program for Molecular Replacement , 1997 .

[53]  D. Eisenberg,et al.  Assessment of protein models with three-dimensional profiles , 1992, Nature.

[54]  Joachim Müller,et al.  Evaluation of Giardia lamblia thioredoxin reductase as drug activating enzyme and as drug target , 2016, International journal for parasitology. Drugs and drug resistance.

[55]  A. Iglesias,et al.  Entamoeba histolytica thioredoxin reductase: molecular and functional characterization of its atypical properties. , 2012, Biochimica et biophysica acta.

[56]  L. Netto,et al.  Insights into the specificity of thioredoxin reductase-thioredoxin interactions. A structural and functional investigation of the yeast thioredoxin system. , 2010, Biochemistry.